Efficacy of bepridil as a periprocedural support drug in atrial fibrillation patients with left ventricular systolic dysfunction undergoing catheter ablation

25 August 2023 (07:30 - 18:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Mr Kosuke Okabe

Fukuoka Red Cross Hospital, Fukuoka (Japan)

5 More presentations in this session

Presentation thumbnail

A genetic polymorphism on chromosome 4q25 (rs17570669_T) may predict atrial fibrillation recurrence after successful electrical cardioversion

Professor T. Ulus (Eskisehir, TR)

Abstract Slides Video

Presentation thumbnail

Efficacy and safety of antiarrhythmic drugs for pharmacological cardioversion of atrial fibrillation depending on gender: a subanalysis of CANT II Study

Associate Professor M. Wybraniec (Katowice, PL)

Abstract Slides Video

Presentation thumbnail

Intravenous infusion of potassium/magnesium solution for the treatment of postoperative atrial fibrillation after coronary artery bypass graft: a randomized, double-blinded, parallel controlled trial

Doctor F. Masoudkabir (Tehran, IR)

Abstract Slides Video

Presentation thumbnail

Development of an in vitro platform for transesophageal echocardiographic and color Doppler hemodynamic assessments of left atrial appendage occlusion devices

Mr Z. Zhong (Munich, DE)

Abstract Slides Video

Presentation thumbnail

Persistence to edoxaban treatment in patients with atrial fibrillation: Analysis from the Global ETNA-AF program

Doctor I. Diemberger (Bologna, IT)

Abstract Slides

Access the full session

Session thumbnail

Cardioversion, antiarrhythmics and antithrombotic management of atrial fibrillation

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources